Adding Epigenetic Drug Was Effective in Pilot Study for PTCL-TFH
Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell...
Read more